Vanderbilt University Medical Center and the University of North Carolina (UNC) at Chapel Hill have been awarded $500,000 by Google’s philanthropy, Google.org, to study how COVID-19 alters gene expression in some people in ways that may be linked to their risk of severe illness and death.

An international group of researchers including Vanderbilt epidemiologists has identified new DNA methylation biomarkers associated with prostate cancer risk.

Sourav Panja, PhD, a postdoctoral scholar in the Department of Pediatrics at Vanderbilt University Medical Center, was working in his lab one evening last year when he began coughing up blood. Even breathing was becoming difficult.

Eric Gamazon, PhD, assistant professor of Medicine, has been awarded a $1.5 million grant from the National Human Genome Research Institute, part of the National Institutes of Health (NIH), to develop novel computational tools that integrate functional genomic data and electronic health records.

Christianne Roumie, MD, MPH, has been named director of the Vanderbilt University School of Medicine Master of Public Health program, a two-year interdisciplinary program accredited by the Council on Education for Public Health.

New findings demonstrate how genetic variations in the receptor that binds SARS-CoV-2 impact virus recognition and infectivity and offer insights to COVID-19 susceptibility and treatment.

Excess dietary salt activates immune cells to induce inflammation and hypertension, supporting current recommendations for low sodium consumption.